CVS Health Corp vs Yum! Brands, Inc. — how do they compare? CVS Health Corp trades at $86.59 (market cap $112.29B), while Yum! Brands, Inc. trades at $143.7 (market cap $39.02B). The key difference: CVS Health Corp is far larger — about 2.9× Yum! Brands, Inc.'s market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Yum! Brands, Inc. for 132 Days on average.
| CVS | YUM | |
|---|---|---|
Market Cap | $112.29B | $39.02B |
Volume | 7,763,676 | 2,597,636 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $168.16 |
52-Week Low | $70.08 | $135.77 |
Typical Hold Time | 83 Days | 132 Days |
Enterprise Value | $174.64B | $50.63B |
Dividend Yield | 3.03% | 2.1% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
YUM trades at $140.35, up 0.36% today, with a bullish technical signal despite mixed moving averages. Revenue grew to $8.21B in 2025, with net income of $1.56B and strong cash flow. Recent news highlights KFC's Open House launch and the completed Pizza Hut sale, streamlining the portfolio. Analysts maintain a consensus Buy rating with a $170.44 target, though some express caution amid sector pressures.
The outlook is positive with earnings beats and strategic refocusing, but risks include high debt levels and consumer spending sensitivity. Upside potential exists if growth initiatives succeed, yet investors should weigh competitive and macroeconomic headwinds.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →